Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...

Highly anticipated by electrophysiologists for its innovation and demonstrated safety and efficacy as well as improved ...

The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street’s ...

Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing ...

Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...

Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third ...

The evolving landscape of musculoskeletal interventional oncology treatment for the management of painful bone metastases.

For instance, the acquisition of Farapulse gave Boston solid footing to compete in the evolution toward pulsed field ablation to treat atrial fibrillation. We're more wary of the recently announced ...

Boston Scientific Corp. posted another eye-popping quarterly report, led by a 177% year-over-year increase in its ...